Electrophysiological effects of risperidone in mammalian cardiac cells

Abstract. In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperidone concentration-dependently lengthened action potential duration in guinea-pig papillary muscles (EC50=0.29±0.02 µM) and single canine ventricular myocytes (EC50=0.48±0.14 µM). This effect was reversible, showed reverse rate dependence, and it was most prominent on the terminal portion of repolarization. No significant effect of risperidone on the resting membrane potential, action potential amplitude or maximum rate of depolarization was observed.In voltage-clamped canine ventricular myocytes risperidone caused concentration-dependent block of the rapid component of the delayed rectifier K+ current (IKr), measured as outward current tails at –40 mV, with an IC50 of 0.92±0.26 µM. Suppression of IKr was not associated with changes in activation or deactivation kinetics. High concentration of risperidone (10 µM) suppressed also the slow component of the delayed rectifier K+ current (IKs) by 9.6±1.5% at +50 mV. These effects of risperidone developed rapidly and were readily reversible. Risperidone had no significant effect on the amplitude of other K+ currents (IK1 and Ito).The inhibition of cardiac IKr current by risperidone may explain the cardiac side-effects observed occasionally with the drug. Our results suggest that risperidone displays class III antiarrhythmic properties, and as such, may produce QTc prolongation, especially in patients with long QT syndrome. Therefore, in psychotic patients having also cardiac disorders, ECG control may be suggested during risperidone therapy.

[1]  Dierk Thomas,et al.  The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. , 2002, The Journal of pharmacology and experimental therapeutics.

[2]  D. Rampe,et al.  The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. , 1998, The Journal of pharmacology and experimental therapeutics.

[3]  M. Tohen,et al.  Risperidone in the elderly: a pharmacoepidemiologic study. , 1997, Journal of Clinical Psychiatry.

[4]  J. Czekalla,et al.  Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. , 2001, The Journal of clinical psychiatry.

[5]  László Virág,et al.  The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization , 2000, The Journal of physiology.

[6]  D. Gardner,et al.  A case of risperidone overdose in early schizophrenia: a review of potential complications. , 1998, Journal of psychiatry & neuroscience : JPN.

[7]  J. Tamargo,et al.  Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. , 1994, Circulation research.

[8]  C. January,et al.  Droperidol Lengthens Cardiac Repolarization due to Block of the Rapid Component of the Delayed Rectifier Potassium Current , 1999, Journal of cardiovascular electrophysiology.

[9]  A H Glassman,et al.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.

[10]  C. Wurthmann,et al.  Randomized, Double‐Blind, Controlled Trial of Risperidone Versus Clozapine in Patients With Chronic Schizophrenia , 1995, Journal of clinical psychopharmacology.

[11]  M. Kamalesh,et al.  Effect of risperidone on QT interval and QT dispersion in the elderly. , 2000, Heart disease.

[12]  S. Ayis,et al.  QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients , 2000, The Lancet.

[13]  D. Flockhart,et al.  Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. , 1998, Journal of clinical psychopharmacology.

[14]  Psychotropic drugs and long QT syndromes: case reports. , 1985, The Journal of clinical psychiatry.

[15]  R. Friedman,et al.  Prolongation of the Corrected QT and Torsades de Pointes Cardiac Arrhythmia Associated with Intravenous Haloperidol in the Medically III , 1993, Journal of clinical psychopharmacology.

[16]  A. Peer,et al.  Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects , 1993, Clinical pharmacology and therapeutics.

[17]  S. Finkel Managing the behavioral and psychological signs and symptoms of dementia , 1997, International clinical psychopharmacology.

[18]  S. Hohnloser,et al.  Proarrhythmia with Class III Antiarrhythmic Drugs: Definition, Electrophysiologic Mechanisms, Incidence, Predisposing Factors, and Clinical Implications , 1995, Journal of cardiovascular electrophysiology.

[19]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[20]  A. Jednákovits,et al.  Electrophysiological effects of bimoclomol in canine ventricular myocytes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[22]  C. McDougle,et al.  A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. , 1998, Archives of general psychiatry.

[23]  Sheng-Nan Wu,et al.  Characterization of Inhibition by Risperidone of the Inwardly Rectifying K+ Current in Pituitary GH3 Cells , 2000, Neuropsychopharmacology.

[24]  B Attali,et al.  The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes , 1997, British journal of pharmacology.

[25]  R Lazzara,et al.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.

[26]  Z. Ungvari,et al.  Electrophysiological effects of fluoxetine in mammalian cardiac tissues , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  J. Levenson,et al.  Fatal Cardiac Event following Initiation of Risperidone Therapy , 1997, The Annals of pharmacotherapy.

[28]  C. Funck-Brentano,et al.  Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans. , 1996, Circulation.

[29]  L. Ereshefsky,et al.  Pharmacological profile of risperidone. , 1993, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[30]  A. Avenoso,et al.  Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone , 1999, Psychopharmacology.

[31]  B. Drolet,et al.  Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. , 1999, The Journal of pharmacology and experimental therapeutics.

[32]  Z. Ungvari,et al.  Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. , 1999, Acta physiologica Scandinavica.

[33]  D. Snyders,et al.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.

[34]  A. S. Davis The pre-clinical assessment of QT interval prolongation: a comparison of in vitro and in vivo methods , 1998, Human & experimental toxicology.

[35]  T. Barnes,et al.  Electrocardiographic changes in patients receiving neuroleptic medication , 1996, Acta psychiatrica Scandinavica.